Envisioning a Transformed Clinical Trials Enterprise in the United States

There is growing recognition that the United States'' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions.

With the need for tra...